Thomas di Maio

Driven by a passion for science and societal impact, Thomas is a Chemistry & Biotechnology scientist whose career in pharmaceuticals has spanned commercial strategy, marketing, and diagnostics. His current focus is pioneering the use of genetic sequencing, AI, and Machine Learning to advance cancer understanding and directly guide patient treatment decisions.